Suppression of Fas-FasL coexpression by erythropoietin mediates erythroblast expansion during the erythropoietic stress response in vivo

Blood
Ying LiuMerav Socolovsky

Abstract

Erythropoietin (Epo) is the principal regulator of the erythropoietic response to hypoxic stress, through its receptor, EpoR. The EpoR signals mediating the stress response are largely unknown, and the spectrum of progenitors that are stress responsive is not fully defined. Here, we used flow cytometry to identify stress-responsive Ter119+CD71highFSChigh early erythroblast subsets in vivo. In the mouse spleen, an erythropoietic reserve organ, early erythroblasts were present at lower frequencies and were undergoing higher rates of apoptosis than equivalent cells in bone marrow. A high proportion of splenic early erythroblasts coexpressed the death receptor Fas, and its ligand, FasL. Fas-positive early erythroblasts were significantly more likely to coexpress annexin V than equivalent, Fas-negative cells, suggesting that Fas mediates early erythroblast apoptosis in vivo. We examined several mouse models of erythropoietic stress, including erythrocytosis and beta-thalassemia. We found a dramatic increase in the frequency of splenic early erythroblasts that correlated with down-regulation of Fas and FasL from their cell surface. Further, a single injection of Epo specifically suppressed early erythroblast Fas and FasL mRNA and cel...Continue Reading

References

Nov 1, 1977·British Journal of Haematology·C PeschleA Soricelli
Apr 21, 1989·Cell·A D D'AndreaG G Wong
Jul 1, 1971·Proceedings of the National Academy of Sciences of the United States of America·J R StephensonM M Shreeve
May 1, 1972·The Journal of Clinical Investigation·T Papayannopoulou, C A Finch
Mar 10, 1995·Science·S Nagata, P Golstein
Jan 1, 1995·Immunology Today·S Nagata, T Suda
Aug 26, 1993·Nature·J OgasawaraS Nagata
Sep 1, 1993·Stem Cells·D M Wojchowski, T C He
Dec 5, 1995·Proceedings of the National Academy of Sciences of the United States of America·B YangO Smithies
Aug 20, 1996·Proceedings of the National Academy of Sciences of the United States of America·M W KieranL I Zon
Nov 14, 1997·Trends in Biochemical Sciences·P VillaW C Earnshaw
May 14, 1999·Trends in Endocrinology and Metabolism : TEM·S N ConstantinescuH F Lodish
Dec 1, 1999·The Journal of Cell Biology·C RaoulB Pettmann
Dec 2, 1999·Experimental Cell Research·D M WojchowskiT J Pircher
Dec 2, 1999·Genes & Development·A BauerH Beug
Feb 15, 2001·Proceedings of the National Academy of Sciences of the United States of America·V H HaaseR Jaenisch
Oct 24, 2001·Journal of Hematotherapy & Stem Cell Research·A OdaK Sawada
Jun 1, 2002·Science·Harald Wajant
Jun 18, 2002·Journal of Cellular and Molecular Medicine·R NatL M Popescu
Sep 23, 2003·Cellular Signalling·James F Curtin, Thomas G Cotter

❮ Previous
Next ❯

Citations

Nov 29, 2012·Pharmaceutical Research·Xiaoyu YanWojciech Krzyzanski
Dec 24, 2011·International Journal of Hematology·Kazuki TaokaMineo Kurokawa
Jul 16, 2013·Cell Death and Differentiation·M Ridinger-SaisonC Guillouf
Jun 4, 2013·Nature Communications·Shun YamazakiMasayuki Yamamoto
Jan 26, 2010·Nature Medicine·Huihui LiYelena Z Ginzburg
Apr 16, 2010·The Journal of Biological Chemistry·Shaobin WangMing-Hui Zou
Nov 14, 2012·The Journal of Experimental Medicine·Wayne R AustinCaius G Radu
Apr 17, 2009·Biology of Reproduction·Michelle T NortonElizabeth A Bonney
Nov 14, 2006·The Journal of Trauma·Yohan RobinsonAndreas Oberholzer
Apr 7, 2007·Current Opinion in Hematology·Merav Socolovsky
Mar 5, 2011·Current Opinion in Hematology·Robert F PaulsonDai-Chen Wu
Mar 5, 2011·Current Opinion in Hematology·Jing LiuXiuli An
Aug 4, 2010·Genes & Development·Duonan YuMitchell J Weiss
Jul 4, 2007·The Journal of Clinical Investigation·Xiang YuMitchell J Weiss
Nov 2, 2012·The Journal of Clinical Investigation·Qingdu LiuVolker H Haase
Mar 8, 2007·Blood·Abigail A LamikanraDavid J Roberts
Dec 26, 2008·Blood·Catherine L CarmichaelHamish S Scott
May 2, 2013·Nanoscale Research Letters·Guangbo QuGuibing Jiang
Sep 28, 2007·PLoS Biology·Merav SocolovskyAndre Levchenko
Oct 1, 2009·PloS One·Jan-Rung MoEric S Bachman
Jun 10, 2011·PloS One·Yu-An CaoChristopher H Contag
Feb 13, 2009·Haematologica·Hongmei TangDaishu Han
Sep 2, 2011·Haematologica·Tatsiana Ripich, Rolf Jessberger
Aug 19, 2011·Journal of Visualized Experiments : JoVE·Miroslav KoulnisMerav Socolovsky
Jul 7, 2011·Indian Journal of Medical and Paediatric Oncology : Official Journal of Indian Society of Medical & Paediatric Oncology·Ajay Gupta, Lalit Kumar
Sep 15, 2011·Immunotherapy·Emanuela MarcenaroSimona Sivori
Apr 23, 2013·TheScientificWorldJournal·Jean-Antoine RibeilOlivier Hermine
Dec 5, 2013·Physiological Reports·Zhenghui WangJohannes Vogel
Dec 10, 2015·Experimental Hematology·Mark J Koury
Jul 5, 2013·Experimental Hematology·Christopher R DowdyGary S Stein

❮ Previous
Next ❯

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis